Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) für Autoimmune Conditions

B

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Fazit

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

Key Study Findings

Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None vs.: None Outcome: rheumatoid arthritis disease activity modulation through diet Wirkung: None None

Population: patients with rheumatoid arthritis

Case Reports n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None vs.: None Outcome: GPIHBP1 autoantibody and LPL mass normalization Wirkung: None None

Population: 12-year-old girl with SLE and severe hypertriglyceridemia

Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None vs.: None Outcome: Epigenetic and mitochondrial modulation in MS Wirkung: None None

Population: Multiple sclerosis patients (review)

Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None vs.: None Outcome: RA risk and disease activity Wirkung: None None

Population: Patients with rheumatoid arthritis

Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: Systematic review of nutraceuticals in rheumatoid arthritis

Key Statistics

10

Studien

25000

Teilnehmer

Positive

B

Bewertung

Referenced Papers

BMJ (Clinical research … 2022 9 Zitierungen
Nederlands tijdschrift voor … 2022 1 Zitierungen
Current opinion in … 2005 26 Zitierungen
Current atherosclerosis reports 2004 464 Zitierungen
Journal of the … 2002 2016 Zitierungen
Biochemical Society transactions 1995 15 Zitierungen
World review of … 1994 8 Zitierungen
The American journal … 1991 2278 Zitierungen
Rheumatic diseases clinics … 1991 19 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

Obergrenze: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None -- Positive 1
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Neutral --

Beste Einnahmezeit: With meals

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

Bekannte Wechselwirkungen

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

Tolerierbare Höchstaufnahmemenge: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Autoimmune Conditions

Omega-3 Fatty Acids (EPA/DHA) für andere Beschwerden

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.